The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells
Epigenetic modifying enzymes have a crucial role in the pathogenesis of acute myeloid leukemia (AML). Methylation of lysine 9 on histone H3 by the methyltransferase G9a and SUV39H1 is associated with inhibition of tumor suppressor genes. We studied the effect of G9a and SUV39H1 inhibitors on viabili...
Main Authors: | Lai, Y-S, Chen, J-Y, Tsai, H-J, Chen, T-Y, Hung, W-C |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476016/ |
Similar Items
-
Alternative splicing regulates the expression of G9A and SUV39H2 methyltransferases, and dramatically changes SUV39H2 functions
by: Mauger, Oriane, et al.
Published: (2015) -
Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA
by: Scarola, Michele, et al.
Published: (2015) -
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL)1
by: Mutonga, Martin, et al.
Published: (2015) -
The Epigenetic Landscape of Acute Myeloid Leukemia
by: Conway O'Brien, Emma, et al.
Published: (2014) -
Role of Epigenetics in Chronic Myeloid Leukemia
by: Machova Polakova, Katerina, et al.
Published: (2013)